MedPath

A feasibility randomised controlled trial of a peer-delivered disclosure programme (Let’s Talk) for internalised stigma experienced by people with psychosis

Not Applicable
Completed
Conditions
Psychosis
Mental and Behavioural Disorders
Unspecified nonorganic psychosis
Registration Number
ISRCTN17197043
Lead Sponsor
Greater Manchester Mental Health NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria

1. Age 16+ years
2. Meet ICD-10 F20-F29 Schizophrenia spectrum diagnosis, or be receiving services from Early Intervention Services (EIS)
3. Under the care of a mental health service with a care coordinator
4. Competent to provide written, informed consent (for ethical considerations)
5. At least a moderate level of self-reported disclosure-related distress screening scale (Rüsch et al., 2014), as determined by scoring >3 on the screening item
6. At least moderate levels of internalised stigma as determined by a a score of =3 on at least one of the Internalised Stigma domains the Semi-structured Interview Measure of Stigma (Wood et al., 2016)

Exclusion Criteria

1. A primary diagnosis of alcohol or substance dependency (ICD-10 F10 – F19 diagnosis), where this is clearly the cause of their psychotic symptoms. This does not exclude people who use substances or alcohol, only those with a primary diagnosis. This will be confirmed by the participant's care coordinator or psychiatrist
2. A diagnosis of moderate to severe learning disability, as confirmed by the participant's care coordinator or psychiatrist
3. An ICD-10 diagnosis of organic psychosis, as confirmed by the participant's care coordinator or psychiatrist
4. Non-English speaking, where this prevents engagement in informed written consent and interviews
5. Immediate risk to self or others as confirmed by the participant's care coordinator or psychiatrist

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath